MGMT and neoplasm: For the 5 patients with low tumor MGMT expression, 3 displayed a nuclear DDR biomarker response to treatment, whereas 1 did not and 1 was not assessable due to insufficient tumor tissue in the on-treatment biopsy (Figure 3B).